Nantahala Capital Management, LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:35 pm Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 1,001,350 1.990% | -1,626,301 (-61.89%) | Filing |
| 2025-04-30 5:15 pm Sale | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 2,627,651 5.600% | -1,721,784 (-39.59%) | Filing |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 4,349,435 9.990% | 398,148 (+10.08%) | Filing |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 3,951,287 9.990% | 3,951,287 (New Position) | Filing |